Stay updated on Risdiplam in SMA Infants Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Infants Clinical Trial page.

Latest updates to the Risdiplam in SMA Infants Clinical Trial page
- Check5 days agoChange DetectedA new site revision tag Revision: v3.4.3 has been added, and the previous Revision: v3.4.2 tag has been removed.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedA new site revision is displayed (Revision: v3.4.2), and a prior funding/operating status notice has been removed. These are administrative updates to the site and do not affect the study details or user interactions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding and updated operating status was added, and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded 'Show glossary' feature and updated page metadata (Last Update Submitted that Met QC Criteria: 2026-01-07; Last Update Posted: 2026-01; No FEAR Act Data; Revision: v3.4.0). Older revision data (Revision: v3.3.4) and earlier dates were removed — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedThe page now displays revision v3.3.4, replacing v3.3.3. This appears to be a minor metadata update with no substantive changes to the study content.SummaryDifference0.1%

- Check83 days agoChange DetectedStudy Locations updated to include Florida, New South Wales, São Paulo, and Moscow Oblast; related location entries were adjusted.SummaryDifference0.5%

Stay in the know with updates to Risdiplam in SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Infants Clinical Trial page.